Quimica Sintetica Sa, based in Spain, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is DROXIDOPA, with a corresponding US DMF Number 32264.
Remarkably, this DMF maintains an Active status since its submission on November 24, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 08, 2018, and payment made on December 06, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II